Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study

Chunfang Qiu, Daniel Enquobahrie, Ihunnaya O Frederick, Dejene Abetew, Michelle A Williams, Chunfang Qiu, Daniel Enquobahrie, Ihunnaya O Frederick, Dejene Abetew, Michelle A Williams

Abstract

Background: Insufficient sleep and poor sleep quality, considered endemic in modern society, are associated with obesity, impaired glucose tolerance and diabetes. Little, however, is known about the consequences of insufficient sleep and poor sleep quality during pregnancy on glucose tolerance and gestational diabetes.

Methods: A cohort of 1,290 women was interviewed during early pregnancy. We collected information about sleep duration and snoring during early pregnancy. Results from screening and diagnostic testing for gestational diabetes mellitus (GDM) were abstracted from medical records. Generalized linear models were fitted to derive relative risk (RR) and 95% confidence intervals (95% CIs) of GDM associated with sleep duration and snoring, respectively.

Results: After adjusting for maternal age and race/ethnicity, GDM risk was increased among women sleeping < or = 4 hours compared with those sleeping 9 hours per night (RR = 5.56; 95% CI 1.31-23.69). The corresponding RR for lean women (<25 kg/m2) was 3.23 (95% CI 0.34-30.41) and 9.83 (95% CI 1.12-86.32) for overweight women (> or = 25 kg/m2). Overall, snoring was associated with a 1.86-fold increased risk of GDM (RR = 1.86; 95% CI 0.88-3.94). The risk of GDM was particularly elevated among overweight women who snored. Compared with lean women who did not snore, those who were overweight and snored had a 6.9-fold increased risk of GDM (95% CI 2.87-16.6).

Conclusions: These preliminary findings suggest associations of short sleep duration and snoring with glucose intolerance and GDM. Though consistent with studies of men and non-pregnant women, larger studies that include objective measures of sleep duration, quality and apnea are needed to obtain more precise estimates of observed associations.

Figures

Figure 1
Figure 1
Maternal mean plasma glucose concentrations after a 50-g glucose challenge. Means are adjusted for maternal age and race/ethnicity. Error bars are standard errors.
Figure 2
Figure 2
Maternal mean 1-hour plasma glucose concentrations after a 50-g oral glucose challenge. (a). Proportion (%) of women with 1-hour glucose concentrations ≥ 140 mg/dl (b). Values are plotted for the entire cohort (black), lean (body mass index < 25 kg/m2, blue) and overweight (body mass index ≥ 25 kg/m2, red) women, respectively.

References

    1. IOM. Institute of Medicine, Committee on Sleep Medicine and Research. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Washington, DC: National Academy of Sciences Press; 2006.
    1. Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008;133(2):496–506. doi: 10.1378/chest.07-0828.
    1. Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27(3):440–444.
    1. Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2):380–384. doi: 10.2337/diacare.26.2.380.
    1. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205–209. doi: 10.1001/archinte.163.2.205.
    1. Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, Ewy GA, Howard BV, Punjabi NM. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care. 2003;26(3):702–709. doi: 10.2337/diacare.26.3.702.
    1. Parish JM, Adam T, Facchiano L. Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med. 2007;3(5):467–472.
    1. Schuster SR, Tabba M, Sahota P. Relationship between the cardiometabolic syndrome and obstructive sleep apnea. J Cardiometab Syndr. 2006;1(3):204–208. doi: 10.1111/j.1559-4564.2006.05846.x.
    1. Meisinger C, Heier M, Loewel H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia. 2005;48(2):235–241. doi: 10.1007/s00125-004-1634-x.
    1. Mallon L, Broman JE, Hetta J. High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care. 2005;28(11):2762–2767. doi: 10.2337/diacare.28.11.2762.
    1. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3):657–661. doi: 10.2337/diacare.29.03.06.dc05-0879.
    1. Okcay A, Somers VK, Caples SM. Obstructive sleep apnea and hypertension. J Clin Hypertens (Greenwich) 2008;10(7):549–555. doi: 10.1111/j.1751-7176.2008.07811.x.
    1. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165(5):670–676.
    1. Levy P, Bonsignore MR, Eckel J. Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J. 2009;34(1):243–260. doi: 10.1183/09031936.00166808.
    1. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009;51(5):434–451. doi: 10.1016/j.pcad.2009.01.002.
    1. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439. doi: 10.1016/S0140-6736(99)01376-8.
    1. Spiegel K, Leproult R, L'Hermite-Baleriaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab. 2004;89(11):5762–5771. doi: 10.1210/jc.2004-1003.
    1. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol. 2005;99(5):2008–2019. doi: 10.1152/japplphysiol.00660.2005.
    1. Schmid SM, Jauch-Chara K, Hallschmid M, Schultes B. Mild sleep restriction acutely reduces plasma glucagon levels in healthy men. J Clin Endocrinol Metab. 2009;94(12):5169–5173. doi: 10.1210/jc.2009-0969.
    1. Schmid SM, Hallschmid M, Jauch-Chara K, Bandorf N, Born J, Schultes B. Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia. J Clin Endocrinol Metab. 2007;92(8):3044–3051. doi: 10.1210/jc.2006-2788.
    1. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL, Peters A. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med. 2004;169(11):1231–1237. doi: 10.1164/rccm.200308-1200OC.
    1. Cutler MJ, Swift NM, Keller DM, Wasmund WL, Smith ML. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol. 2004;96(2):754–761. doi: 10.1152/japplphysiol.00506.2003.
    1. Iiyori N, Alonso LC, Li J, Sanders MH, Garcia-Ocana A, O'Doherty RM, Polotsky VY, O'Donnell CP. Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med. 2007;175(8):851–857. doi: 10.1164/rccm.200610-1527OC.
    1. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, Schwartz AR, O'Donnell CP. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol. 2003;552(Pt 1):253–264. doi: 10.1113/jphysiol.2003.048173.
    1. International Classification of Sleep Disorders Revised: Diagnostic and Coding Manual. Rochester, MN: American Academy of Sleep Medicine; 2000. pp. 14–17.
    1. Hedman C, Pohjasvaara T, Tolonen U, Suhonen-Malm AS, Myllylä VV. Effects of pregnancy on mothers' sleep. Sleep Med. 2002;3(1):37–42. doi: 10.1016/S1389-9457(01)00130-7.
    1. Pien GW, Schwab RJ. Sleep disorders during pregnancy. Sleep. 2004;27(7):1405–1417.
    1. ADA. Gestational diabetes mellitus. Diabetes Care. 2004;27(Suppl 1):88–90.
    1. Hardin JW, Hilbe J. Generalized Linear Models and Extensions. College Station, TX: Stata Press; 2001.
    1. Baker RJ, Nelder JA. The Generalized Linear Interactive Modeling System release 3.77. Oxford: Oxford Numerical Algorithms Group; 1985.
    1. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd version. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 261–263.
    1. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol. 2002;155(5):387–393. doi: 10.1093/aje/155.5.387.
    1. Chaput JP, Despres JP, Bouchard C, Tremblay A. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia. 2007;50(11):2298–2304. doi: 10.1007/s00125-007-0786-x.
    1. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep. 2007;30(12):1667–1673.
    1. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci. 2008;1129:287–304. doi: 10.1196/annals.1417.033.
    1. Jennum P, Sjol A. Snoring, sleep apnoea and cardiovascular risk factors: the MONICA II Study. Int J Epidemiol. 1993;22(3):439–444. doi: 10.1093/ije/22.3.439.
    1. Lindberg E, Berne C, Franklin KA, Svensson M, Janson C. Snoring and daytime sleepiness as risk factors for hypertension and diabetes in women--a population-based study. Respir Med. 2007;101(6):1283–1290. doi: 10.1016/j.rmed.2006.10.015.
    1. Elmasry A, Lindberg E, Berne C, Janson C, Gislason T, Awad Tageldin M, Boman G. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med. 2001;249(2):153–161. doi: 10.1046/j.1365-2796.2001.00787.x.
    1. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology. 2008;19(6):838–845. doi: 10.1097/EDE.0b013e318187a7b0.
    1. Bliwise DL, Nekich JC, Dement WC. Relative validity of self-reported snoring as a symptom of sleep apnea in a sleep clinic population. Chest. 1991;99(3):600–608. doi: 10.1378/chest.99.3.600.
    1. Gislason T, Benediktsdóttir B, Björnsson JK, Kjartansson G, Kjeld M, Kristbjarnarson H. Snoring, hypertension, and the sleep apnea syndrome. An epidemiologic survey of middle-aged women. Chest. 1993;103(4):1147–1151. doi: 10.1378/chest.103.4.1147.
    1. Jennum P, Hein HO, Suadicani P, Gyntelberg F. Risk of ischemic heart disease in self-reported snorers. A prospective study of 2,937 men aged 54 to 74 years: the Copenhagen Male Study. Chest. 1995;108(1):138–142. doi: 10.1378/chest.108.1.138.
    1. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Levy P. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol. 2009;31(1):113–125. doi: 10.1007/s00281-009-0148-5.
    1. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AL. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009;32(4):447–470.
    1. Kumari M, Badrick E, Ferrie J, Perski A, Marmot M, Chandola T. Self-reported sleep duration and sleep disturbance are independently associated with cortisol secretion in the Whitehall II study. J Clin Endocrinol Metab. 2009;94(12):4801–4809. doi: 10.1210/jc.2009-0555.
    1. Vgontzas AN, Bixler EO, Chrousos GP. Metabolic disturbances in obesity versus sleep apnea: the importance of visceral obesity and insulin resistance. J Intern Med. 2003;254(1):32–44. doi: 10.1046/j.1365-2796.2003.01177.x.
    1. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med. 2000;162(2 Pt 1):566–570.
    1. Meier-Ewert HK, Ridker PM, Rifai N, Regan MM, Price NJ, Dinges DF, Mullington JM. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678–683. doi: 10.1016/j.jacc.2003.07.050.
    1. Okun ML, Hall M, Coussons-Read ME. Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod Sci. 2007;14(6):560–567. doi: 10.1177/1933719107307647.
    1. Okun ML, Coussons-Read ME. Sleep disruption during pregnancy: how does it influence serum cytokines? J Reprod Immunol. 2007;73(2):158–165. doi: 10.1016/j.jri.2006.06.006.
    1. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol. 2004;18(5):377–384. doi: 10.1111/j.1365-3016.2004.00578.x.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere